AstriVax Therapeutics logo

AstriVax Therapeutics

Pioneering immune interventions to treat chronic disease

38 employees · est. 2022 · Belgium

VS
RUTI Immune logo

RUTI Immune

Invest in Ruti Immune, developing a unique vaccine that enhances "trained innate immunity" against Covid-19 and other viruses.

est. 2020 · Badalona, Spain

RUTI Immune is the older company (2022 vs 2020).

Side-by-Side Comparison

AstriVax Therapeutics RUTI Immune
Founded
2022 2020 older
Headquarters
Belgium Badalona, Spain
Employees
38 Not tracked yet
Industry
Not tracked yet Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Grant Equity Crowdfunding
Total Funding
$35.50M $1.60M
Funding Rounds
3 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Vaccinology, Vaccine Technology, DNA-based Technology, Live Attenuated Viruses, Infectious Diseases, Vaccine Development, Cold Chain Requirements, Broad-spectrum Protection, Pathogen Prevention, Clinical Validation, Vaccination Pipeline Vaccine Development, Trained Innate Immunity, Ruti Vaccine, Covid-19, Virus Mutations, Virus Strains, Global Impact, Medical Innovation
Website
astrivax.com rutiimmune.com
AstriVax Therapeutics logo

About AstriVax Therapeutics

AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is committed to addressing real-world challenges in vaccinology by building a first-in-class Plug & Play vaccine platform with a patented DNA-based...

RUTI Immune logo

About RUTI Immune

RUTI Immune is a biopharmaceutical startup founded in 2020 and is based in Spain. The company is dedicated to developing a unique vaccine that enhances "trained innate immunity" against Covid-19 and other viruses. It is promoted by ARCHIVEL FARMA, the owner of the renowned RUTI vaccine, which has gr...

We will tell you when either one moves

BounceWatch watches AstriVax Therapeutics and RUTI Immune for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AstriVax Therapeutics and RUTI Immune — by email.

Frequently Asked Questions

AstriVax Therapeutics — Pioneering immune interventions to treat chronic disease. RUTI Immune — Invest in Ruti Immune, developing a unique vaccine that enhances "trained innate immunity" against Covid-19 and other viruses.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AstriVax Therapeutics has raised $35.50M while RUTI Immune has raised $1.60M.
AstriVax Therapeutics and RUTI Immune operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AstriVax Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AstriVax Therapeutics on 11 Sep 2024, and RUTI Immune on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy